These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Segmentally enclosed thrombolysis in percutaneous transluminal angioplasty for femoropopliteal occlusions: a report from a pilot study. Jørgensen B; Tønnesen KH; Nielsen JD; Holstein P; Bülow J; Jørgensen M; Andersen E Cardiovasc Intervent Radiol; 1991; 14(5):293-8. PubMed ID: 1834337 [TBL] [Abstract][Full Text] [Related]
5. Femoral artery recanalisation with percutaneous angioplasty and segmentally enclosed plasminogen activator. Jørgensen B; Tønnesen KH; Bülow J; Nielsen JD; Jørgensen M; Holstein P; Andersen E Lancet; 1989 May; 1(8647):1106-8. PubMed ID: 2566052 [TBL] [Abstract][Full Text] [Related]
6. Prolonged binding of radiolabeled recombinant tissue-type plasminogen activator after angioplasty and enclosed thrombolysis of the femoropopliteal arteries. Tønnesen KH; Vinberg N; Folkenborg O J Vasc Interv Radiol; 1992 Nov; 3(4):627-32. PubMed ID: 1446124 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous transluminal angioplasty and enclosed thrombolysis versus percutaneous transluminal angioplasty in the treatment of femoropopliteal occlusions: results of a prospective randomized trial. Nicholson T Cardiovasc Intervent Radiol; 1998; 21(6):470-4. PubMed ID: 9853164 [TBL] [Abstract][Full Text] [Related]
8. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty. Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313 [TBL] [Abstract][Full Text] [Related]
9. Cross-linked fibrin degradation products (XL-FDP) as marker of early rethrombosis in percutaneous transluminal angioplasty. Jørgensen B; Nielsen JD; Nørgård J; Helligsø P; Baekgaard N; Egeblad M Eur J Vasc Surg; 1993 Nov; 7(6):720-4. PubMed ID: 8270079 [TBL] [Abstract][Full Text] [Related]
10. Plasma level changes of fibrinopeptide A after uncomplicated coronary angioplasty. Manolis AS; Melita-Manolis H; Stefanadis C; Toutouzas P Clin Cardiol; 1993 Jul; 16(7):548-52. PubMed ID: 8348763 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of intraarterial plasminogen application in combination with percutaneous transluminal angioplasty (PTA) or catheter assisted lysis (CL) in patients with chronic peripheral occlusive disease of the lower limbs (POL). Tilsner V; Witte G Haemostasis; 1988; 18 Suppl 1():139-56. PubMed ID: 2965085 [TBL] [Abstract][Full Text] [Related]
12. Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. Granger CB; Becker R; Tracy RP; Califf RM; Topol EJ; Pieper KS; Ross AM; Roth S; Lambrew C; Bovill EG J Am Coll Cardiol; 1998 Mar; 31(3):497-505. PubMed ID: 9502626 [TBL] [Abstract][Full Text] [Related]
13. Fibrin metabolism in patients with acute myocardial infarction during and after treatment with tissue-type plasminogen activator. Ring ME; Butman SM; Bruck DC; Feinberg WM; Corrigan JJ Thromb Haemost; 1988 Dec; 60(3):428-33. PubMed ID: 2976994 [TBL] [Abstract][Full Text] [Related]
14. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors. Weitz JI; Leslie B; Hudoba M Circulation; 1998 Feb; 97(6):544-52. PubMed ID: 9494024 [TBL] [Abstract][Full Text] [Related]
15. [Percutaneous transluminal angioplasty (PTA) by the Gruntzig balloon catheter in arterial occlusive diseases of the limbs]. Nakayama Y; Uraguchi K; Ooishi K; Koga M; Tashiro T Rinsho Kyobu Geka; 1982 Nov; 2(6):785-94. PubMed ID: 6220457 [No Abstract] [Full Text] [Related]
16. [Doppler sonography diagnosis of restenosis after percutaneous transluminal angioplasty: sensitivity and specificity of the pedal-brachial index in relation to changes in absolute arterial blood pressure]. Radak Dj; Laps KH; Jeger KA; Ilijevski N; Vojić M Srp Arh Celok Lek; 1998; 126(3-4):83-91. PubMed ID: 9863361 [TBL] [Abstract][Full Text] [Related]
17. More accurate assessment of stenotic lesions in percutaneous transluminal angioplasty. Janevski BK; Breslau PJ; Jorning PJ Int Angiol; 1986; 5(2):97-103. PubMed ID: 2943842 [TBL] [Abstract][Full Text] [Related]
18. Percutaneous recanalization of total iliac and femoro-popliteal artery occlusions. Graziani L Eur J Radiol; 1987 May; 7(2):91-3. PubMed ID: 2954822 [TBL] [Abstract][Full Text] [Related]